We are live on ! Find out more
Jeffrey R. Jay

Jeffrey R. Jay Portfolio holdings

AUM $127M
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
–
Cap. Flow
+$113M
Cap. Flow %
89.09%
Top 10 Hldgs %
72.25%
Holding
32
New
31
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0 years
Avg Time Held Equity only
0 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0 years

Top Buys

Rank Stock Value
1
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
+$21.1M
2
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
+$17.3M
3
STML
Stemline Therapeutics, Inc.
STML
+$9.48M
4
AMBI icon
Ambit Biosciences Corp
AMBI
+$7.15M
5
FLNA icon
Filana Therapeutics
FLNA
+$7.01M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 51.22%
2 Miscellaneous 48.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PTN icon
26
Palatin Technologies
PTN
$10M
$1.06M 0.84%
+1,370
New +$1.05M
2013 Q2
0 quarters
VASC
27
DELISTED
Vascular Solutions Inc
VASC
$680K 0.54%
+46,200
New +$727K
2013 Q2
0 quarters
IMNN icon
28
Imunon
IMNN
$6.85M
$190K 0.15%
+15
New +$208K
2013 Q2
0 quarters
AORT icon
29
Artivion
AORT
$1.16B
$164K 0.13%
+26,244
New +$160K
2013 Q2
0 quarters
GWPH
30
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$102K 0.08%
+11,622
New +$103K
2013 Q2
0 quarters
AMAG
31
DELISTED
AMAG Pharmaceuticals
AMAG
$3K ﹤0.01%
+150
New +$3.3K
2013 Q2
0 quarters
1
2

Similar funds

Cazenove Capital Management
Cazenove Capital Management London, United Kingdom $125M AUM
TP
Traxis Partners Greenwich, Connecticut $129M AUM
Telemus Beacon Investment
Telemus Beacon Investment Ann Arbor, Michigan $94.1M AUM
RRWJ
R. Robert Woodburn Jr $93.1M AUM
MIA
Mainstream Investment Advisers New Albany, Indiana $163M AUM
FLC
Francis L. Coolidge $82.2M AUM
HSA
Holt-Smith Advisors Madison, Wisconsin $70.9M AUM
NM
NBGE Manager Waltham, Massachusetts $65.2M AUM

Jeffrey R. Jay's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Jeffrey R. Jay, which disclosed 32 positions worth $127M. Its ten largest holdings account for 72% of the portfolio.

Its largest position is HYPERION THERAPEUTICS INC COM STK (DE): 963,961 shares worth $21.2M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, followed by Miscellaneous.

  • Jeffrey R. Jay's largest Q2 2013 buy was HYPERION THERAPEUTICS INC COM STK (DE): 963,961 shares worth $21.2M.
  • Jeffrey R. Jay's ten largest holdings make up 72% of its $127M portfolio in Q2 2013.
  • Jeffrey R. Jay disclosed 32 positions in Q2 2013, its first 13F filing on record.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.